ATRAID regulates the action of nitrogen-containing bisphosphonates on bone
Abstract
ATRAID is essential for responses to the commonly prescribed osteoporosis drugs nitrogen-containing bisphosphonates.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 20, 2020
- Source ID
- 10.1126/scitranslmed.aav9166
Entities
People
- Abbhirami Rajagopal
- Brendan Lee
- Charles C Gu
- Cheng Lyu
- Chris M McAndrew
- Christina Gurnett
- Christina L Costantino
- Damon T Burrow
- Daniel Haber
- David M. Sabatini
- Fei Wan
- Gabe Haller
- Jan E. Carette
- Jinmei Li
- Jiwoong Park
- Jonathan C Baker
- Kathryn Diemer
- Kristen M. Shannon
- Kıvanç Birsoy
- Lauren E Surface
- Mahshid Mohseni
- Malini Varadarajan
- Margaret Huskey
- Melissa Sum
- Michael J. Gardner
- Niki Song
- Noopur Raje
- Roberto Civitelli
- Sandeep Kumar
- Shenghui Duan
- Steven Mumm
- Thijn Brummelkamp
- Thomas B Dodson
- Timothy R Peterson
- Vinieth N Bijanki
- William M. Ricci
- Yangjin Bae
- Zhou Yu
Organizations
- Austrian Academy of Sciences
- Baylor College of Medicine
- Harvard Medical School
- Harvard School of Dental Medicine
- Harvard University
- Hospital for Special Surgery
- Howard Hughes Medical Institute
- Jane Coffin Childs Memorial Fund for Medical Research
- LAM Foundation
- Massachusetts Institute of Technology
- NYU Langone Health
- National Cancer Institute
- National Institute of Arthritis and Musculoskeletal and Skin Diseases
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute on Aging
- National Institutes of Health
- Oncode Institute
- Shriners Hospitals for Children
- Stanford University
- The Rockefeller University
- United States Department of Defense
- W. M. Keck Foundation
- Washington University School of Medicine
- Washington University in St. Louis
- Whitehead Institute